FTC approves application for Fresenius to establish dialysis clinic in Michigan

By Mark Iandolo | Dec 28, 2017

WASHINGTON (Legal Newsline) — The Federal Trade Commission (FTC) announced Dec. 19 it has approved an application by Fresenius Medical Care AG & Co. KGaA, allowing the company to establish a new outpatient clinic in a location where it previously divested a clinic.

WASHINGTON (Legal Newsline) — The Federal Trade Commission (FTC) announced Dec. 19 it has approved an application by Fresenius Medical Care AG & Co. KGaA, allowing the company to establish a new outpatient clinic in a location where it previously divested a clinic.

On Feb. 28, 2012, Fresenius sold 60 dialysis clinics throughout the United States after a settlement with the FTC. After the divestiture, Fresenius was allowed to complete its acquisition of Liberty Dialysis Holdings Inc. As per the agreement, however, Fresenius could not reacquire any interest in the clinics it divested unless it received FTC approval.

Fresenius can establish a new clinic in Wyoming, Michigan—a location involved in the previous settlement.

The FTC voted 2-0 to approve the application. Eric D. Rohlck of the Bureau of Competition is the staff contact for the case.


Want to get notified whenever we write about U.S. Federal Trade Commission ?

Sign-up Next time we write about U.S. Federal Trade Commission , we'll email you a link to the story. You may edit your settings or unsubscribe at any time.

Organizations in this Story

U.S. Federal Trade Commission

More News

The Record Network